These findings suggest that ERK3 itself may not be able to transform normal epithelial cells, but is capable of promoting cancer cell growth and invasiveness once cells are transformed following the loss‐of‐function mutation of tumor suppressor gene or gain‐of‐function mutation(s) of oncogenes. The gene discussed is MAPK6; the disease is cancer.